Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: A nationwide population-based cohort study

Mocroft A, 1998, Lancet, 352, 1725, 10.1016/S0140-6736(98)03201-2

Palella FJ, 1998, N Engl J Med, 338, 853, 10.1056/NEJM199803263381301

Lohse N, 2007, Ann Intern Med, 146, 87, 10.7326/0003-4819-146-2-200701160-00003

Mocroft A, 2004, AIDS, 18, 2333, 10.1097/00002030-200411190-00018

Lucas GM, 2006, Am J Epidemiol, 163, 412, 10.1093/aje/kwj059

Rodriguez-Arenas MA, 2006, AIDS Res Hum Retroviruses, 22, 715, 10.1089/aid.2006.22.715

Larsen M, 2009, Addiction, 105, 529, 10.1111/j.1360-0443.2009.02827.x

Prins M, 2000, AIDS, 14, 1829, 10.1097/00002030-200008180-00019

Vlahov D, 2005, Am J Epidemiol, 161, 999, 10.1093/aje/kwi133

Celentano DD, 2007, Clin Infect Dis, 45, S318, 10.1086/522557

Kitahata MM, 2009, N Engl J Med, 360, 1815, 10.1056/NEJMoa0807252

Strathdee SA, 1998, JAMA, 280, 547, 10.1001/jama.280.6.547

Chaisson RE, 1995, N Engl J Med, 333, 751, 10.1056/NEJM199509213331202

Wood E, 2003, CMAJ, 169, 656

Lohse N, 2005, Scand J Infect Dis, 37, 338, 10.1080/00365540510031692

Obel N, 2009, Int J Epidemiol, 38, 1202, 10.1093/ije/dyn192

Jensen-Fangel S, 2002, Clin Infect Dis, 35, 1541, 10.1086/344769

Weber R, 2009, HIV Med, 10, 407, 10.1111/j.1468-1293.2009.00701.x

Wood E, 2009, BMJ, 338, b1649, 10.1136/bmj.b1649

Celentano DD, 2001, AIDS, 15, 1707, 10.1097/00002030-200109070-00015

Wood E, 2005, AIDS, 19, 1189, 10.1097/01.aids.0000176219.48484.f1

Gulick RM, 2004, N Engl J Med, 350, 1850, 10.1056/NEJMoa031772

Jorgensen LB, 2003, Scand J Infect Dis, 35, 800, 10.1080/00365540310016916

Weis N, 2006, Clin Infect Dis, 42, 1481, 10.1086/503569